Stock screenerAll disclosures →
EDGAR →
XNCR
Conviction 88HealthcareScan · Mon, Aug 10, 2026XNCR$21.60+3.77%
ResistanceSupportVol 14Insider sellVol MA14 1.07M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price21.60
Change+3.77%
Gap+0.50%
Rel volume1.81×
Avg volume1.15M
Avg $ vol22.51M
SMA 2019.14
SMA 5015.81
SMA 20013.99
Price vs 50+36.58%
Price vs 200+54.41%
MA stackbullish
50/200 cross—
Supertrendup · 16.93
RSI (14)69
MACD hist-0.02
MACD crossbear · 4d
Stoch %K / %D88 / 69
ADX (14)56
+DI / −DI35 / 7
RSI divergenceBearish
MACD divergenceBearish
ATR %+6.18%
ADR %7.50%
52w high21.60
52w low7.00
From 52w high+0.00%
Above 52w low+208.50%
New 52w highYes
SqueezeOff
Bollinger width40.79%
%B0.82
Donchian pos95.18%
Donchian high21.96
Donchian low14.38
AVWAP (52w high)20.86
vs AVWAP high+3.51%
AVWAP (52w low)13.42
vs AVWAP low+60.97%
OBV trendUp
Chaikin MF (20)0.19
Today vs 20d1.81×
Avg vol (14d)1.07M
Avg vol (20d)1.15M
Avg $ vol (20d)22.51M
Market cap1.61B
RS 3m (vs SPY)+63.35%
RS 6m (vs SPY)+78.21%
RS line new highNo
Trend template6/8
Technical rank95.2
1 week+11.31%
1 month+36.25%
3 months+67.92%
6 months+86.00%
1 year+195.01%
YTD+44.74%
P/E-17.47
P/B3.19
P/S12.79
P/FCF-11.61
EPS-1.24
Div yield—
ROE-18.27%
ROA-12.68%
Debt/Eq0.21
Current6.39
EV/EBITDA-9.98
Gross margin—
Net margin-73.20%
Rev growth13.65%
EPS growth60.48%
Price target28.25
Target upside30.82%
Analyst ratingBuy
Institutional125.41%
Ent. value1.67B
Revenue51.22M
Net income-21.73M
Gross profit—
Free cash flow-138.27M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out74.14M
Employees260
ListedTue, Dec 3, 2013
Free float74.14M
Float %100.0%
Short interest10.84M
Days to cover13.6d
Short volume84.6%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.29 vs −$0.82
Last surprise+64.6% beat
Setup gradeA+
Conviction88 / 100
Pattern quality—
Tech rank95.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance21.86
Support13.14
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJun 111 scan
- Breaking out nowJun 121 scan
Congress activity
Disclosed STOCK Act trades in XNCR
No recent disclosed trades by Congress in XNCR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in XNCR · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Deshaies Raymond Joseph Director · Stock Option (Right to Buy) · 2026-06-16 | Grant | 20.6K | — | 2026-06-16 | 2026-07-08 |
Deshaies Raymond Joseph Director · Common Stock · 2026-06-16 | Grant | 10.3K | — | 2026-06-16 | 2026-07-08 |
Feigal Ellen Director · Common Stock · 2026-06-16 | Grant | 10.3K | — | 2026-06-16 | 2026-07-08 |
Feigal Ellen Director · Stock Option (Right to Buy) · 2026-06-16 | Grant | 20.6K | — | 2026-06-16 | 2026-07-08 |
GORMAN KEVIN CHARLES Director · Common Stock · 2026-06-16 | Grant | 10.3K | — | 2026-06-16 | 2026-07-08 |
GORMAN KEVIN CHARLES Director · Stock Option (Right to Buy) · 2026-06-16 | Grant | 20.6K | — | 2026-06-16 | 2026-07-08 |
GUSTAFSON KURT A Director · Common Stock · 2026-06-16 | Grant | 10.3K | — | 2026-06-16 | 2026-07-08 |
GUSTAFSON KURT A Director · Stock Option (Right to Buy) · 2026-06-16 | Grant | 20.6K | — | 2026-06-16 | 2026-07-08 |
Klencke Barbara Director · Common Stock · 2026-06-16 | Grant | 10.3K | — | 2026-06-16 | 2026-07-08 |
Klencke Barbara Director · Stock Option (Right to Buy) · 2026-06-16 | Grant | 20.6K | — | 2026-06-16 | 2026-07-08 |
SEC filings
EDGAR filings in XNCR · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.